Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations.

Butala S, Castelo-Soccio L, Seshadri R, Simpson EL, O'Shea JJ, Bieber T, Paller AS

Open source

DOI
10.1016/j.jaip.2023.03.011
Published
2023 May
Container
The journal of allergy and clinical immunology. In practice
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaip.2023.03.011,
  title = {Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations.},
  author = {Butala S and Castelo-Soccio L and Seshadri R and Simpson EL and O'Shea JJ and Bieber T and Paller AS},
  year = {2023},
  journal = {The journal of allergy and clinical immunology. In practice},
  doi = {10.1016/j.jaip.2023.03.011},
  url = {https://doi.org/10.1016/j.jaip.2023.03.011}
}

RIS

TY  - JOUR
TI  - Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations.
AU  - Butala S
AU  - Castelo-Soccio L
AU  - Seshadri R
AU  - Simpson EL
AU  - O'Shea JJ
AU  - Bieber T
AU  - Paller AS
PY  - 2023
JO  - The journal of allergy and clinical immunology. In practice
DO  - 10.1016/j.jaip.2023.03.011
UR  - https://doi.org/10.1016/j.jaip.2023.03.011
ER  - 

APA

S, B., L, C., R, S., EL, S., JJ, O., T, B., & AS, P. (2023). Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations.. The journal of allergy and clinical immunology. In practice. https://doi.org/10.1016/j.jaip.2023.03.011

Source records